1. Home
  2. BOLT vs GNLN Comparison

BOLT vs GNLN Comparison

Compare BOLT & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • GNLN
  • Stock Information
  • Founded
  • BOLT 2015
  • GNLN 2005
  • Country
  • BOLT United States
  • GNLN United States
  • Employees
  • BOLT N/A
  • GNLN N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • GNLN Durable Goods
  • Sector
  • BOLT Health Care
  • GNLN Consumer Discretionary
  • Exchange
  • BOLT Nasdaq
  • GNLN Nasdaq
  • Market Cap
  • BOLT 11.5M
  • GNLN 12.9M
  • IPO Year
  • BOLT 2021
  • GNLN 2019
  • Fundamental
  • Price
  • BOLT $4.75
  • GNLN $3.20
  • Analyst Decision
  • BOLT Buy
  • GNLN
  • Analyst Count
  • BOLT 4
  • GNLN 0
  • Target Price
  • BOLT $34.00
  • GNLN N/A
  • AVG Volume (30 Days)
  • BOLT 20.9K
  • GNLN 750.7K
  • Earning Date
  • BOLT 11-14-2025
  • GNLN 11-14-2025
  • Dividend Yield
  • BOLT N/A
  • GNLN N/A
  • EPS Growth
  • BOLT N/A
  • GNLN N/A
  • EPS
  • BOLT N/A
  • GNLN N/A
  • Revenue
  • BOLT $4,167,000.00
  • GNLN $7,954,000.00
  • Revenue This Year
  • BOLT N/A
  • GNLN $1,541.21
  • Revenue Next Year
  • BOLT N/A
  • GNLN N/A
  • P/E Ratio
  • BOLT N/A
  • GNLN N/A
  • Revenue Growth
  • BOLT N/A
  • GNLN N/A
  • 52 Week Low
  • BOLT $4.59
  • GNLN $2.75
  • 52 Week High
  • BOLT $13.80
  • GNLN $2,737.50
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 35.12
  • GNLN 42.32
  • Support Level
  • BOLT $5.65
  • GNLN $3.06
  • Resistance Level
  • BOLT $5.93
  • GNLN $3.27
  • Average True Range (ATR)
  • BOLT 0.35
  • GNLN 0.33
  • MACD
  • BOLT -0.14
  • GNLN -0.03
  • Stochastic Oscillator
  • BOLT 0.00
  • GNLN 25.56

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

Share on Social Networks: